Cisplatin Chemotherapy of Ovarian Cancer: Is Short‐Term In Vitro Chemosensitivity Predictive of Long‐Term Patient Survival?

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 28, Issue 4, 1988, Pages 313-317

  Khoo, S K ^a   Hurst, T ^a   Webb, M J ^b   Dickie, G ^c   Kearsley, J ^c   Parsons, P G ^d   Mackay, E V ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c Queensland Radium Institute   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

CANCER CHEMOTHERAPY; CELL CULTURE; CHEMOSENSITIVITY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVARY CANCER; SURVIVAL;

CISPLATIN; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMAN; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0024273710     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.1988.tb01689.x     Document Type: Article

References (15)

1. Chemosensitivity testing of human solid tumors: a review of 1582 assays with 258 clinical correlations
2. Biochemical short‐term predictive assay: results of correlative trials in comparison to other assay
3. A critical appraisal of the human tumor stem‐cell assay
4. Bench‐to‐bedside research and the human tumor stem‐cell assay — bridging the credibility gap
5. Clinical aspects of second‐look laparotomy in ovarian cancer
6. Chemosensitivity testing of ovarian cancer: results of a rapid in vitro biochemical assay
7. In vitro sensitivity of ovarian cancer as determined by a short‐term biochemical assay: comparison between primary and metastatic sites in the same patient
8. Short‐term in vitro chemosensitivity testing of tumours of the ovary, cervix and uterus
9. Reliability of an in vitro short‐term assay to predict the drug sensitivity of human breast cancer
10. Testing chemosensitivity of human tumours
11. Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy
12. Use of tritiated nucleotide incorporation for prediction of sensitivity ot tumors to cytostatic agents
13. Development of a nucleotide precursor incorporation assay for testing drug sensitivity of human tumors
14. Prediction of the clinical chemotherapeutic response of Stage III lung adenocarcinoma patients by an in vitro short‐term test